搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
2 天
Venus Remedies surges 6% after getting marketing nod for lung cancer drug
Venus Remedies share price hit an intraday high of Rs 355 per share, rising 6 per cent on the BSE in Monday's intraday trade ...
moneycontrol.com
5 天
Venus Remedies bags Marketing Authorization in the Philippines for Chemotherapy agent
Pharma company Venus Remedies bagged a Marketing Authorization nod in the Philippines for Pemetrexed 500mg, an agent used in Chemotherapy while treating lung cancer, sending the share price sharply ...
cnbctv18
5 天
Venus Remedies surges nearly 8% on authorisation to market lung cancer treatment drug in ...
Venus Remedies informed the exchanges on December 6 that it has received the marketing authorisation for Pemetrexed 500mg, a ...
manilatimes
26 天
Junshi Biosciences Announces UK MHRA Approval for Marketing of Toripalimab
SHANGHAI, Nov. 16, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈